Exclusive insight from one of America's largest healthcare insurers
WASHINGTON DC, N/A - May 4, 2017 - The
Market Access for Precision Medicine Summit 2017
(Washington DC, July 18-20)
is here for industry stakeholders to elevate their
roadmap for executing a robust market access strategy
to ensure the approval and commercial success of
targeted
precision medicines
.
Market Access for Precision Medicine Summit is experiencing great traction from the market and is accelerating every week. Amongst a number of exciting updates, we are particularly delighted to announce that
Aetna Medical Director, Dr. Elizabeth Raitz-Cowboy
will be delivering a keynote entitled:
The Payer Perspective on the Value of Precision Medicines in Healthcare.
Market Access for Precision Medicine Summit
is now the only end-to-end forum for pharma and biotech drug developers to bring an
exclusive insight from one of Americas largest healthcare insurers.
Click here to take a look at the event guide.
Our expert speaker faculty includes the likes of:
-
Elizabeth Raitz-Cowboy
, Medical Director,
Aetna
-
Tehseen Salimi
, VP & Head, Medical Affairs,
Trevena
-
Jananki Veeraraghavan
, Senior Scientific Reviewer, CDRH,
FDA
-
Franziska Moeckel
, AVP, Presonalized Health,
Inova Health System
-
Omar Dabbous
, Head of Value & Access,
Halozyme Therapeutics
-
Boxiong Tang
, Senior Director, Global HEOR,
Teva Pharmaceuticals
Click here to view all speakers
R&D pipelines are brimming with targeted therapeutic assets and as testified by the recent PMC study, over 25% of drugs approved last year fall into the precision medicine category. The focus now shifts to regulatory approval and commercial launch.
Market Access for Precision Medicine is curated for drug developers to provide insight on harnessing the likes of health economics, companion diagnostics, RWE and clinical labs to help you achieve your market access goals. Due to the increasing demand for clinical utility and the emphasis on delivering value for all stakeholders, this summit will foster much needed discussion and collaborate to ensure drug and diagnostic products reach the right patient, at the right time and the right cost.
Visit the website for more information
P.S. Discounted rates end on May 12